Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
AMGN's Q4 Earnings & Sales Beat Estimates, Obesity Candidate in Focus
11:22am, Wednesday, 04'th Feb 2026
Amgen delivers Q4 earnings and revenue beat, driven by strong drug volumes, as attention turns to its late-stage MariTide obesity studies.
Why Amgen Stock Is Paying Off Big For Long-Term Investors
10:50am, Wednesday, 04'th Feb 2026
Amgen's (AMGN) decade-long commitment to shareholder value is underscored by a staggering $86 billion capital return program, a feat that firmly establishes the biotech giant as a premier player in th
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Wednesday, 04'th Feb 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Amgen: Strong Mitigation Of LOE Impact, Regulatory Tensions On Tavneos Emerge
07:55am, Wednesday, 04'th Feb 2026
Amgen delivered a strong Q4 2025, exceeding revenue and EPS expectations and guiding for 2026 growth despite major loss of exclusivity headwinds. Key branded products Repatha, Uplizna, Evenity, Imdell
Amgen Inc. (AMGN) Q4 2025 Earnings Call Transcript
08:20pm, Tuesday, 03'rd Feb 2026
Amgen Inc. (AMGN) Q4 2025 Earnings Call Transcript
Here's What Key Metrics Tell Us About Amgen (AMGN) Q4 Earnings
07:01pm, Tuesday, 03'rd Feb 2026
Although the revenue and EPS for Amgen (AMGN) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street
Markets Rotate Back Out of Tech, Q4 Earnings After the Close
06:51pm, Tuesday, 03'rd Feb 2026
Trading sagged mid-day, but only after the Dow hit a new intra-day high.
Amgen (AMGN) Q4 Earnings and Revenues Beat Estimates
06:11pm, Tuesday, 03'rd Feb 2026
Amgen (AMGN) came out with quarterly earnings of $5.29 per share, beating the Zacks Consensus Estimate of $4.76 per share. This compares to earnings of $5.31 per share a year ago.
Market Today: Disney picks D'Amaro; PepsiCo trims prices
05:35pm, Tuesday, 03'rd Feb 2026
Guru Stock PicksT Rowe Price Equity Income Fund has made the following transactions:Reduce in MET by 1.04%Sold out in ADBEAdd in REXR by 1.73%New position in CO
Amgen Logs Higher Fourth-Quarter Revenue on Double-Digit Volume Boost
04:58pm, Tuesday, 03'rd Feb 2026
The biotechnology company reported a quarterly profit of $1.33 billion, attributing its boost in earnings to higher revenue and lower net unrealized losses on equity investments.
Amgen quarterly results beat Street estimates on higher sales, lower tax rate
04:05pm, Tuesday, 03'rd Feb 2026
Amgen on Tuesday reported fourth-quarter financial results that came in ahead of Wall Street expectations, driven by a 7% increase in drug sales and a lower tax rate.
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
04:01pm, Tuesday, 03'rd Feb 2026
THOUSAND OAKS, Calif., Feb. 3, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the comparable periods in 2024.
Atlantic Union Bankshares Corp Purchases 7,055 Shares of Amgen Inc. $AMGN
03:14am, Tuesday, 03'rd Feb 2026
Atlantic Union Bankshares Corp raised its position in Amgen Inc. (NASDAQ: AMGN) by 66.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC)
Wall Street Week Ahead
07:03am, Sunday, 01'st Feb 2026
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Atle Fund Management AB Decreases Holdings in Amgen Inc. $AMGN
03:04am, Sunday, 01'st Feb 2026
Atle Fund Management AB decreased its holdings in Amgen Inc. (NASDAQ: AMGN) by 42.2% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,806
